FY2025 · ended Dec 31, 2025 · Revenue $41.13M, +22.2% YoY · Filed Mar 12, 2026
Koru Medical Systems, Inc. (KRMD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $41.1 million and a net loss of $2.6 million. Free cash flow was -$470,112. As of Jun 30, 2026 it held $8.3 million in cash and investments and $3.3 million in total debt.
Revenue (TTM)
$45.11M
+22.4% vs year-ago TTM
Net income (TTM)
$-1.82M
+59.7% vs year-ago TTM
Operating cash flow (TTM)
$1.39M
+303.9% vs year-ago TTM
Free cash flow (TTM)
$776,653
+135.4% vs year-ago TTM
EPS (TTM)
$-0.04
+60.0% vs year-ago TTM
Dividend per share
None
Shares outstanding
46.37M
+0.9% vs prior year
Net cash
$4.98M
as of Jun 30, 2026
Operating margin
-3.7%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- KRMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Mahwah, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 704440
- Former names
- REPRO MED SYSTEMS INC (until Jun 3, 2022)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $41.1M | $33.6M | $28.5M | $27.9M | $23.5M |
| Operating income | -$3.0M | -$6.4M | -$10.3M | -$10.8M | -$7.0M |
| Net income | -$2.6M | -$6.1M | -$13.7M | -$8.7M | -$4.6M |
| Diluted EPS | -$0.06 | -$0.13 | -$0.30 | -$0.19 | -$0.10 |
| Operating cash flow | $462,405 | -$319,718 | -$4.9M | -$5.4M | -$4.3M |
| Free cash flow | -$470,112 | -$1.6M | -$5.7M | -$8.2M | -$4.7M |
| Total assets | $28.2M | $27.2M | $28.5M | $42.3M | $41.3M |
| Total liabilities | $11.2M | $10.4M | $8.1M | $11.0M | $4.8M |
| Stockholders' equity | $17.0M | $16.8M | $20.4M | $31.3M | $36.5M |
| Cash and investments | $8.9M | $9.6M | $11.5M | $17.4M | $25.3M |
| Total debt | $3.5M | $3.7M | $4.1M | $4.5M | $95,553 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 14, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 30, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2026 | May 19, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
All 963 Koru Medical Systems, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.